title: [Erythema multiforme, aplasia, cholestatic hepatitis during treatment with Augmentin (amoxicillin + clavulanic acid)].
authors.affiliation: Service de Dermatologie, Hôpital du Bocage, Dijon.
authors.forename: F
authors.initials: F
authors.lastname: Escallier
authors.forename: S
authors.initials: S
authors.lastname: Dalac
authors.forename: D
authors.initials: D
authors.lastname: Caillot
authors.forename: C
authors.initials: C
authors.lastname: Boulitrop
authors.forename: E
authors.initials: E
authors.lastname: Collet
authors.forename: D
authors.initials: D
authors.lastname: Lambert
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000658:Amoxicillin / Q000009:adverse effects*; D019980:Amoxicillin-Potassium Clavulanate Combination; D000741:Anemia, Aplastic / Q000139:chemically induced*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002779:Cholestasis / Q000139:chemically induced; D002969:Clavulanic Acids / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004892:Erythema Multiforme / Q000139:chemically induced*; D006801:Humans; D008297:Male
chemical_list: D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin
vernacular_title: Erythème polymorphe, aplasie, hépatite cholestatique au cours d'un traitement par Augmentin (amoxicilline + acide clavulanique).